Tag: CBIS
Cannabis Science, Inc. Announces New Company Website, New Management Team Expansions, & Pushes to Complete Updated Financial Reporting Requirements
Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is.
A New Catalyst Pushes Cannabis Science Inc (OTCMKTS:CBIS) Shares
By James Hudson – June 10, 2018 One stock that has recently held support and started to bounce.
Cannabis Science Issues First 2018 Guidance Report; 4/20 Court Date Set For Lawsuit Against San Joaquin County
Cannabis Science Inc., President & CEO IRVINE, CA, April 10, 2018 (GLOBE NEWSWIRE) — Cannabis.
CBIS Ceo Eyes 4/20 for a CBIS Pharmacy Grand Opening Party
IRVINE, CA , March 27, 2018 (GLOBE NEWSWIRE) — Cannabis Science, Inc. (CBIS), a U.S..
Neumann Capital Management Has Increased Its Mckesson (MCK) Stake; Cannabis Science (CBIS) Sentiment Is 1.33
Evgen Dobrzhanskiy Cannabis Science Inc (CBIS) investors sentiment 1.33 in 2017 Q4. It’s in 2017Q3..
Cannabis Science Expands 5-Year Agreement With Dana-Farber Cancer Institute
IRVINE, CA , Feb. 02, 2018 (GLOBE NEWSWIRE) — Cannabis Science, Inc., (OTC: CBIS) a.